Patents by Inventor Mark Allen Sanner

Mark Allen Sanner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6562964
    Abstract: Compounds of the formula (I): wherein A, Y, R, X, R1, R2, R3 and R4 are as defined above are inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders involving nerve damage.
    Type: Grant
    Filed: January 23, 2002
    Date of Patent: May 13, 2003
    Assignee: Pfizer Inc
    Inventors: Mark Ian Kemp, Michael John Palmer, Mark Allen Sanner, Martin James Wythes
  • Patent number: 6372736
    Abstract: Compounds of the formula (I): wherein A, Y, R, X, R1, R2, R3 and R4 are as defined above are inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders involving nerve damage.
    Type: Grant
    Filed: July 21, 1999
    Date of Patent: April 16, 2002
    Assignee: Pfizer INC
    Inventors: Mark Ian Kemp, Michael John Palmer, Mark Allen Sanner, Martin James Wythes
  • Patent number: 6284757
    Abstract: This invention relates to the use of compounds of formula I wherein R1, R2, R3, X, m and n are defined as in the specification, and their pharmaceutically acceptable salts, for the treatment of disorders of the serotonin system.
    Type: Grant
    Filed: August 11, 1999
    Date of Patent: September 4, 2001
    Assignee: Pfizer Inc.
    Inventor: Mark Allen Sanner